Pelthos Therapeutics PTHS
NYSE PTHS
$21.50 +0.29 (+1.37%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Revenue (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) posted Revenue of $15.6 million for Q2 2026, up 43.1% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Revenue (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Pelthos Therapeutics was $43.3 million; for FY2025, it was $16.8 million.

  • According to Business Quant data, Revenue for the three prior quarters was $10.91 million (Q1 2026), $9.39 million (Q4 2025) and $7.41 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 Pelthos Therapeutics 79.95 Mn -8.44 Mn 11.99 Mn 15.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.60 Mn
Mar 31, 2026 10.91 Mn
Dec 31, 2025 9.39 Mn
Sep 30, 2025 7.41 Mn
API Access

Pelthos Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=PTHS&period=max&api_key=YOUR_API_KEY